Dr. Nabarun Dasgupta is the Chief Science Officer of Epidemico, a public health informatics and data firm, owned by Booz Allen Hamilton. He has a decade and half of experience in pharmaceutical sciences, a career encompassing manufacturing and quality, supply chain monitoring, Phase II and III clinical trials, pharmacovigilance and risk management. Dr. Dasgupta is a quantitative epidemiologist by training who worked with and for diverse groups on reducing the negative consequences of medicine use, including for the World Health Organization, non-profit organizations, local health departments, and the pharmaceutical industry. Dr. Dasgupta has pushed innovation in pharmacovigilance including developing official mobile apps for adverse event reporting (US, UK, Netherlands, Croatia), and social media monitoring for adverse events and supply chain irregularities.